Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone therapy

समान संसाधन

• Continued improvement in cardiac T2*with deferasirox treatment over 2 years: Results from the extension of epic cardiac substudy in beta-thalassaemia patients with myocardial siderosis
  द्वारा: Pennell, D., और अन्य
  प्रकाशित: (2010)
• Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
  द्वारा: Alpendurada Francisco, और अन्य
  प्रकाशित: (2012-01-01)
• Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients
  द्वारा: Nargesbeygom Mirbehbahani, और अन्य
  प्रकाशित: (2015-01-01)
• Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trial
  द्वारा: Anuja Premawardhena, और अन्य
  प्रकाशित: (2024-02-01)
• Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major
  द्वारा: Khaled M. Musallam, और अन्य
  प्रकाशित: (2011-02-01)